PKA-CREB signaling suppresses tau transcription

Journal of Alzheimer's Disease

Volumn 46, Issue 1, 2015, Pages 239-248

  Liu, Huanliang ^a,b   Jin, Xiaoxia ^b   Yin, Xiaomin ^a,b   Jin, Nana ^b,c   Liu, Fei ^b,c   Qian, Wei ^a,b  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

CRE; CREB; PKA; tau; transcriptional regulation

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN CRE1; PROTEIN CRE2; PROTEIN CRE3; TAU PROTEIN; UNCLASSIFIED DRUG; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; RETINOIC ACID;

ALZHEIMER DISEASE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR PATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; TRANSCRIPTION INITIATION; TRANSFORMED CELL LINE; TUMOR CELL LINE;

CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CREB-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TAU PROTEINS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TRETINOIN;

EID: 84929324112     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142610     Document Type: Article

References (42)

1. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72, 1858-1862.
2. Drechsel DN, Hyman AA, Cobb MH, Kirschner MW (1992) Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 3, 1141-1154.
3. Belkadi A, LoPresti P (2008) Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line. J Neurochem 107, 351-360.
4. Liu CW, Lee G, Jay DG (1999) Tau is required for neurite outgrowth and growth cone motility of chick sensory neurons. Cell Motil Cytoskeleton 43, 232-242.
5. Morita T, Sobue K (2009) Specification of neuronal polarity regulated by local translation of CRMP2 and Tau via the mTOR-p70S6K pathway. J Biol Chem 284, 27734-27745.
6. Sennvik K, Boekhoorn K, Lasrado R, Terwel D, Verhaeghe S, Korr H, Schmitz C, Tomiyama T, Mori H, Krugers H, Joels M, Ramakers GJ, Lucassen PJ, Van Leuven F (2007) Tau-4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/knockout mice. FASEB J 21, 2149-2161.
7. Yoshizaki C, Tsukane M, Yamauchi T (2004) Overexpres-sion of tau leads to the stimulation of neurite outgrowth, the activation of caspase 3 activity, and accumulation and phos-phorylation of tau inneuroblastoma cells on cAMP treatment. Neurosci Res 49, 363-371.
8. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8, 663-672.
9. Hernandez F, Avila J (2007) Tauopathies. Cell Mol Life Sci 64, 2219-2233.
10. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
11. Arriagada PV, Marzloff K, Hyman BT (1992) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42, 1681-1688.
12. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta-amyloid-induced neurotoxic-ity. Proc Natl Acad Sci U S A 99, 6364-6369.
13. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
14. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739, 198-210.
15. Wang JZ, Liu F (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85, 148-175.
16. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer's disease. J Cell Biol 143, 777-794.
17. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingels-son M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481.
18. Montminy MR, Bilezikjian LM (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somato-statin gene. Nature 328, 175-178.
19. Comb M, Birnberg NC, Seasholtz A, Herbert E, Goodman HM (1986) A cyclic AMP-and phorbol ester-inducible DNA element. Nature 323, 353-356.
20. Short JM, Wynshaw-Boris A, Short HP, Hanson RW (1986) Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains. J Biol Chem 261, 9721-9726.
21. Walker WH, Sanborn BM, Habener JF (1994) An isoform of transcription factor CREM expressed during spermato-genesis lacks the phosphorylation domain and represses cAMP-induced transcription. Proc Natl Acad Sci U S A 91, 12423-12427.
22. Frank DA, Greenberg ME (1994) CREB: A mediator of longterm memory from mollusks to mammals. Cell 79, 5-8.
23. Flavell SW, Greenberg ME (2008) Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu Rev Neurosci 31, 563-590.
24. Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A, Tronche F, Kellendonk C, Gau D, Kapfhammer J, Otto C, Schmid W, Schutz G (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31, 47-54.
25. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002) Amyloid beta-peptide inhibitionofthe PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99, 13217-13221.
26. Shi J, Qian W, Yin X, Iqbal K, Grundke-Iqbal I, Gu X, Ding F, Gong CX, Liu F (2011) Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: A mechanism involved in tau pathology of Alzheimer's disease. J Biol Chem 286, 14639-14648.
27. Khatoon S, Grundke-Iqbal I, Iqbal K (1992) Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: A radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 59, 750-753.
28. Andreadis A, Wagner BK, Broderick JA, Kosik KS (1996) A tau promoter region without neuronal specificity. J Neu-rochem 66, 2257-2263.
29. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23, 4878-4884.
30. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. (2005) MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942.
31. Benito E, Barco A (2010) CREB's control of intrinsic and synaptic plasticity: Implications for CREB-dependent memory models. Trends Neurosci 33, 230-240.
32. Sakamoto K, Karelina K, Obrietan K (2011) CREB: A multifaceted regulator of neuronal plasticity and protection. J Neurochem 116, 1-9.
33. Lonze BE, Ginty DD (2002) Function and regulationofCREB family transcription factors in the nervous system. Neuron 35, 605-623.
34. Pugazhenthi S, Wang M, Pham S, Sze CI, Eckman CB (2011) Downregulation of CREB expression in Alzheimer's brain and in Abeta-treated rat hippocampal neurons. Mol Neurode-gener 6, 60.
35. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114, 1624-1634.
36. Tong L, Thornton PL, Balazs R, Cotman CW (2001) Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem 276, 17301-17306.
37. Tong L, Balazs R, Thornton PL, Cotman CW (2004) Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci 24, 6799-6809.
38. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampusofindividuals with Alzheimer's disease.Neuron 7, 695-702.
39. Pugazhenthi S, Nesterova A, Jambal P, Audesirk G, Kern M, Cabell L, Eves E, Rosner MR, Boxer LM, Reusch JE (2003) Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. J Neurochem 84, 982-996.
40. Jin N, Qian W, Yin X, Zhang L, Iqbal K, Grundke-Iqbal I, Gong CX, Liu F (2013) CREB regulates the expressionofneu-ronal glucose transporter 3: A possible mechanism related to impaired brain glucose uptakeinAlzheimer's disease.Nucleic Acids Res 41, 3240-3256.
41. Fink JS, Verhave M, Kasper S, Tsukada T, Mandel G, Goodman RH (1988) The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc Natl Acad Sci U S A 85, 6662-6666.
42. Craig JC, Schumacher MA, Mansoor SE, Farrens DL, Brennan RG, Goodman RH (2001) Consensus and variant cAMP-regulated enhancers have distinct CREB-binding properties. J Biol Chem 276, 11719-11728.